The revenue stands at ₹521.17 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.98 per cent from ₹578.96 crore. This corresponds to a year-on-year *(YoY) decline of 2.24 per cent.
Operating Profit stands at ₹44.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 465.40 per cent from ₹7.92 crore. This corresponds to a year-on-year *(YoY) decline of 47.64 per cent.
PBDT stands at ₹324.68 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,472.30 per cent from ₹20.65 crore. This corresponds to a year-on-year *(YoY) growth of 251.42 per cent.
Profit Before Tax stands at ₹293.43 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2,811.92 per cent from ₹-10.82 crore. This corresponds to a year-on-year *(YoY) growth of 374.42 per cent.
Net Profit stands at ₹264.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2,322.79 per cent from ₹-11.89 crore. This represents a 356.85 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | 0.15% | 0.34% | -3.18% | 4.44% | -18.13% | -41.99% |
| Bliss GVS Pharma | 1.56% | 4.50% | 11.38% | 33.13% | 76.67% | 136.99% |
| Dishman Carbogen | -7.27% | 4.18% | 12.06% | 7.68% | -15.70% | -22.44% |
| Gufic BioScience | 1.22% | 5.40% | -1.06% | 3.78% | -17.10% | -22.74% |
| Panacea Biotec | -0.94% | 2.89% | 17.57% | 23.31% | 20.36% | -20.69% |
| Hikal | 0.17% | 4.56% | 9.76% | 0.81% | -5.91% | -49.23% |
| Morepen Labs. | -0.33% | 3.80% | 0.52% | -5.44% | -0.53% | -35.54% |
Non-Executive & Non-Independent Director : Pranay Godha
Managing Director : Pabitra Bhattacharya
Company Sec. & Compli. Officer : Pradeep Bhandari
Chairman (Non-Executive) : Prakash A Mody
Independent Director : Anand T Kusre
Independent Director : Arun Todarwal
Independent Director : Swati Patankar